Webinars and Commercial Conversations — Register Now

Tuesday, December 1, 2026, 1 PM-2 PM ET

Join UCSF clinical microbiologists as they share their journey from using multiple respiratory testing platforms to implementing a flexible, stewardship-driven testing strategy. Learn how customizable respiratory panels helped streamline workflows, improve efficiency, and better align testing with patient needs.

Webinar presenters Danielle Ingebrigtsen, MHS, Clinical Laboratory Scientist Supervisor, UCSF Health, and Rama Yakubu, MD, PhD, Assistant Professor of Laboratory Medicine, Co-Director of Microbiology, UCSF Health.

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diasorin.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers

Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute

CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, January 12, 2027, 2 PM-3 PM ET
Hear Dr. Roden discuss how computational pathology will impact the practice & future of precision oncology, using global real world analytical evidence for the novel TROP2 NMR biomarker as an example.

Webinar presenter Anja C. Roden, MD, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Professor of Laboratory Medicine and Pathology
Mayo Clinic College of Medicine and Science, Rochester, Minnesota

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Roche Diagnostics. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

August 2025

Put It on the Board

August 2025—In a position statement released in July, the CAP urged policymakers to consider scientific and logistical evidence and to protect the integrity and safety of the national blood supply. The statement was issued in response to legislation proposed in several states that would require blood product labeling based on donor vaccination status or mandate hospitals and blood collectors to honor requests for directed and autologous donations. Misinformation surrounding COVID-19 and mRNA vaccines has led to a growing number of patient requests for blood transfusions exclusively from unvaccinated donors.

Systemic Mastocytosis: Overview of Disease and Diagnosis for Pathologists

Webinar presenter Sheeja Pullarkat, MD, on behalf of Blueprint Medicines, Professor of Pathology and Laboratory Medicine, Director of Hematopathology Fellowship Program, Hematopathology and Hematology, UCLA Health, discusses Systemic Mastocytosis (SM), SM evaluation and diagnostic work-up, and technical challenges and best practices for optimizing testing. Moderated by Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast June 2, 2022.

Community-based rapid NGS offers considerable advantages in clinical cancer care

Webinar presenter Brandon Sheffield, MD, Anatomic and Molecular Pathologist, Department of Laboratory Medicine, William Osler Health System, discusses William Osler Health System’s experience with implementing next-generation sequencing (NGS) in routine oncology biomarker testing. In their pilot study, 578 pan-cancer solid tumor samples underwent genomic profiling. All testing was performed by one group of technologists within the same division of the laboratory, achieving a median turnaround time (TAT) of 3 business days. Dr. Sheffield will elaborate on the importance of timely availability of biomarker results for optimal cancer care, demostrate the feasibility of such TATs in community-based hospitals using fast and automated NGS, and describe the novel approach of integrating NGS with routine immunohistochemistry. Moderated by Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast August 3, 2022.

Methylation Analysis: A new approach to sarcoma classification

Webinar presenters Andreas von Deimling, MD, Department of Neuropathology, Institute of Pathology, University Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and Christian Kölsche, MD, Department of General Pathology, Institute of Pathology, University Hospital Heidelberg, discuss sarcoma classification by DNA methylation profiling, principles of methylation-based tumor classification, approaches to sarcomas with methylation analysis, and practical examples and outlook of accessing the tool. Moderated by: Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast July 20, 2022.